Kforce Inc. Q1 2008 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2008. Kforce Inc. is a provider of professional staffing services and solutions operating through four segments: Technology, Finance and Accounting, Health and Life Sciences, and Government Solutions. The company operates 67 field offices in the United States and has international operations in the Philippines comprising less than 1% of revenue.
Key Financial Metrics
| Metric | Q1 2008 | Q1 2007 |
|---|---|---|
| Net Service Revenues | $264.5 million | $252.3 million |
| Gross Profit | $90.2 million | $88.4 million |
| Gross Margin | 34.1% | 35.1% |
| Operating Income | $12.7 million | $16.1 million |
| Net Income | $7.2 million | $8.8 million |
| Diluted EPS | $0.18 | $0.21 |
| Cash from Operations | $14.2 million | $9.4 million |
| Long-Term Debt | $56.1 million | $53.0 million (Dec 2007) |
| Cash and Equivalents | $0.8 million | $1.1 million (Dec 2007) |
Material Changes vs. Prior Period
- Revenue Growth: Net service revenues increased 4.8% year-over-year, driven by growth in the Technology (2.9%), Health and Life Sciences (16.7%), and Government Solutions (26.8%) segments. The Finance and Accounting segment declined 6.4% due to the conclusion of high-volume projects and a decline in mortgage-related client needs.
- Margin Compression: Gross profit margin decreased 100 basis points to 34.1%. This was primarily caused by a decline in search fees (which carry 100% gross profit) and a contraction in the spread between bill rates and pay rates in flexible staffing.
- Expense Increases: Selling, general, and administrative (SG&A) expenses rose to 27.8% of revenue from 27.3%. Increases were attributed to higher compensation costs, stock-based compensation ($1.7 million vs. $1.2 million), and bad debt expense.
- Share Repurchases: The company repurchased 1.5 million shares for $13.0 million during the quarter. The Board increased the repurchase authorization by $50.0 million in February 2008.
Outlook, Risks, and Unusual Items
- Subsequent Event: On April 29, 2008, Kforce agreed to sell its Scientific business (part of the Health and Life Sciences segment) for $10.5 million in cash, subject to adjustments and earn-outs. The results of this business will be reported as a discontinued operation beginning in Q2 2008.
- Economic Risks: Management notes growing concerns regarding the macro-economic environment, including declining GDP growth and rising unemployment. A U.S. recession would likely have a significant adverse impact on the business.
- Liquidity: The company maintains a $140 million Credit Facility. As of March 31, 2008, $53.0 million was outstanding with $60.2 million available. Management believes existing resources are adequate for the next 12 months.
- Forward-Looking Statements: The filing contains projections regarding revenue and income that are subject to risks and uncertainties, including the integration of acquisitions and effects of interest rate variations.
Investor Verification Checklist
- Verify the impact of the pending sale of the Scientific business on future segment reporting and goodwill allocation.
- Monitor the trend in the Finance and Accounting segment, specifically the recovery from the decline in mortgage-related staffing needs.
- Assess the sustainability of the 100 basis point gross margin compression in the context of the broader economic slowdown.
- Review the utilization of the $50 million increase in share repurchase authorization and its impact on cash reserves.
- Confirm the status of the $10.5 million sale proceeds and any potential earn-out payments from the Scientific business divestiture.